Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,599 | -17,602 | -7,711 | -11,048 | -32,474 |
| Depreciation Amortization | N/A | N/A | 8 | 113 | 118 |
| Accounts receivable | N/A | N/A | -306 | -357 | -23 |
| Other Working Capital | -2,364 | 1,643 | 1,583 | -821 | -610 |
| Other Operating Activity | 19,163 | 1,148 | 522 | 723 | 22,132 |
| Operating Cash Flow | $-35,800 | $-14,811 | $-5,904 | $-11,389 | $-10,856 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 3 | -2 | -5 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -346 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 803 |
| Investing Cash Flow | $N/A | $N/A | $3 | $-2 | $453 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23,216 | 100,303 | 14,193 | 7,931 | 545 |
| Other Financing Activity | 15,298 | -433 | -624 | 0 | 9,193 |
| Financing Cash Flow | $38,514 | $99,870 | $13,569 | $7,931 | $9,737 |
| Beginning Cash Position | 94,851 | 9,792 | 2,124 | 5,584 | 6,250 |
| End Cash Position | 97,565 | 94,851 | 9,792 | 2,124 | 5,584 |
| Net Cash Flow | $2,714 | $85,059 | $7,668 | $-3,460 | $-666 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,800 | -14,811 | -5,904 | -11,389 | -10,856 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -5 |
| Free Cash Flow | -35,800 | -14,811 | -5,904 | -11,389 | -10,862 |